Image Source : Krish Capital Pty Ltd
Index Update: U.S. stock futures opened sharply lower as investor sentiment weakened amid rising concerns over the country's fiscal health and economic outlook. The decline followed Moody’s downgrade of the U.S. credit rating due to increasing debt and a growing budget deficit. Additional pressure came from a congressional committee's approval of President Trump’s unfunded tax-cut package, intensifying fears about long-term fiscal sustainability. Weak economic data from the prior week and broad losses in mega-cap tech stocks further contributed to the market sell-off.
Market Movers: On Friday, the top gainers were Inozyme Pharma, Inc (+177.82%), followed by Cabaletta Bio, Inc (+17.68%). On the contrary Travere Therapeutics, Inc (-14.89%) and Carbon Revolution Public Limited Company (-13.12%) declined the most the same day.
Commodities Update: Crude oil prices declined, with WTI falling to around $62.1 per barrel and Brent to $65, pressured by weak economic data from China and a U.S. credit rating downgrade by Moody’s. Slower industrial output and retail sales in China raised doubts about its economic recovery, while concerns about the U.S. fiscal outlook further dampened sentiment. However, losses were cushioned by uncertainty over Iran-U.S. nuclear talks, which could influence global oil supply, and ongoing geopolitical discussions, including a planned call between U.S. President Trump and Russia's President Putin on the Ukraine conflict.Gold prices rebounded above $3,220 per ounce following their sharpest weekly decline in six months. The recovery was driven by safe-haven demand amid growing worries about the U.S. economic outlook and rising fiscal deficits after Moody’s downgraded the U.S. credit rating. While gold fell previously due to optimism over a U.S.-China tariff truce, recent weaker inflation data and sluggish U.S. indicators have strengthened expectations for more Fed rate cuts, providing further support for the precious metal.
Macro Update: U.S. Treasury yields rose sharply, with the 10-year nearing 4.55% and the 30-year surpassing 5%, amid heightened fiscal concerns following Moody’s downgrade of the U.S. credit rating. The move reflects investor anxiety over rising government debt and a widening budget deficit, intensified by the approval of President Trump’s large, unfunded tax-cut proposal. Despite the fiscal strain, the administration argues the cuts will spur growth and boost revenues. Meanwhile, markets still expect two Fed rate cuts later this year, likely in September and December.
Futures Update: U.S. stock index futures dropped significantly after Moody’s downgraded its investment grade rating on the country, intensifying concerns about economic slowdown and rising debt levels. The Dow Jones, S&P 500, and Nasdaq 100 futures all posted notable declines. This pullback follows a strong performance in the previous week, where major indices surged on optimism surrounding a temporary tariff reduction deal between the U.S. and China. The Nasdaq led the gains, followed by the S&P 500 and the Dow, which moved into positive territory for the year.

After initially showing a lack of direction, stocks mostly moved higher throughout Friday's trading session. The S&P 500 increased by 41.45 points (0.70%), closing at 5,958.37. Technical analysis suggests that the current price is in a confluence zone that previously acted as resistance, indicating a possible period of consolidation with a bearish bias in the near term, as noted in earlier commentary. However, the upcoming golden cross of key moving averages signals a potential shift toward an overall positive trend. Support levels are expected around 5,777, while resistance may be near 5,977.






Please wait processing your request...